toceranib phosphate

01/01/2015 - "Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia®) in Dogs with Spontaneous Malignancies."
12/01/2022 - "Toceranib phosphate is used to treat several feline cancers and is well tolerated. "
12/01/2022 - "Toceranib phosphate resolves right heart obstruction secondary to a heart base neoplasm in a dog."
06/01/2022 - "The role of toceranib phosphate in dogs with non-mast cell neoplasia: A systematic review."
01/01/2022 - "Tumor tissue obtained from the patient was assessed using an anticancer drug response prediction test, and the results showed that toceranib phosphate was the most effective chemotherapeutic agent for this patient. "

10/01/2021 - "This is the first study to report the MST in dogs with stages III and IV nasal carcinoma treated with toceranib phosphate. "
12/01/2017 - "Preliminary studies have supported use of toceranib phosphate (Palladia®) in treatment of canine nasal carcinomas, though the mechanisms of its activity are unknown. "
10/01/2021 - "This retrospective study showed that toceranib phosphate decreases the clinical signs associated with nasal carcinomas."
10/01/2021 - "Twenty-three dogs with a confirmed nasal carcinoma treated with toceranib phosphate and with a CT scan for initial staging according to Adams Modified Staging System were included. "
10/01/2021 - "To determine the median survival time (MST) of dogs with nasal carcinoma treated with toceranib phosphate. "

11/01/2023 - "Palmar-plantar erythrodysesthesia syndrome resulting from toceranib phosphate in a dog with apocrine gland anal sac adenocarcinoma: a case report."
05/01/2020 - "Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs."
01/01/2020 - "We report a case of an 8-year-old male neutered domestic shorthair cat weighing 5.8 kg diagnosed with pancreatic adenocarcinoma treated with surgical resection and toceranib phosphate, which had a progression-free interval of 1148 days and survived for more than 1436 days. "
01/01/2020 - "Long-term survival in a cat with pancreatic adenocarcinoma treated with surgical resection and toceranib phosphate."
04/15/2019 - "To assess response and outcome in dogs with stage 4 anal sac apocrine gland adenocarcinoma (ASAGA) treated with toceranib phosphate as the sole chemotherapeutic agent. "

03/01/2020 - "In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models."
03/01/2018 - "Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma."
10/01/2017 - "Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma."
06/01/2022 - "Results of the study support that toceranib phosphate may have efficacy against certain types of neoplasia under certain conditions, such as neuroendocrine tumours, gastrointestinal stromal tumours and anal sac adenocarcinomas, while it is probably not effective for the management of metastatic osteosarcoma based on the findings of the review."
06/23/2022 - "This is the first case report documenting the complete resolution of vertebral osteosarcoma lesions after treatment with doxorubicin followed by toceranib phosphate. "

10/05/2021 - "Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate."
01/01/2019 - "Toceranib phosphate has been shown to be an efficacious therapy for canine mast cell tumors with increasing evidence that it may be beneficial in the medical management of neuroendocrine tumors."